Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Executive Order Reduces Childhood Vaccine Recommendations
Published 3 months, 1 week ago
Description
In today's Pharmaceutical Executive Daily, a new report finds U.S. rare disease biotech investment rebounding after FDA's Priority Review Voucher program renewal, President Trump signs an executive order narrowing the recommended childhood vaccine schedule, and BeOne Medicines and Revolution Medicines announce a multi-part oncology collaboration.